Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma

NCT01874054

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +7 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Pacific Hematology Oncology Associates San Francisco, California, United States

Stanford Cancer Center Stanford, California, United States

Oncology Institute of Hope & Innovation, The Whittier, California, United States

View all 13 locations

View Trial Details

Completed

Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas

NCT02076451

Conditions: Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Sarah Cannon Research Institute / Tennesee Oncology Nashville, Tennessee, United States

View Trial Details

Completed

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

NCT01588678

Conditions: Adenocarcinoma, Advanced Solid Tumor, Carcinoma, +23 more
Locations: South Texas Accelerated Research Therapeutics San Antonio, Texas, United States

View Trial Details

Completed

Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome

NCT00057967

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Northwestern University, Northwestern Medical Faculty Foundation Chicago, Illinois, United States

Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States

View Trial Details

Completed

Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT02142049

Conditions: Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, Hemic and Lymphatic Diseases, +7 more
Locations: SITE-1 Duarte, California, United States

SITE-2 Los Angeles, California, United States

SITE-10 Orange, California, United States

SITE-3 Chicago, Illinois, United States

View Trial Details

Completed

Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies

NCT00943319

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Reduced Intensity Double Umbilical Cord Blood Transplantation

NCT01408563

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies.

NCT01715623

Conditions: Children With HSP, Healthy Volunteers, Hemic and Lymphatic Diseases, +8 more
Locations: Clinical Investigation Center Limoges, France

Nephrology Limoges, France

Pediatric Limoges, France

Pneumology Limoges, France

View Trial Details

Completed

Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides

NCT00103246

Conditions: Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +23 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma

NCT03811457

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Liaocheng People Hospital Liaocheng, Shandong, China

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions